Alkermes plc. (ALKS): Operating Cash Flow
$520.75M
Year ended 2025-12-31
$251.18M
Trailing 12 months to 2026-06-30
+191.4%
3-year compound annual growth
+44.4%
5-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $520.75M | +18.6% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $439.12M | +9.4% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $401.35M | n/m | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $21.04M | -79.3% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $101.72M | +22.8% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $82.84M | +14.9% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $72.08M | -27.4% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $99.28M | +417.4% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $19.19M | n/m | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | -$63.80M | n/m | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | -$40.36M | n/m | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $11.14M | -92.4% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $147.53M | n/a | 2016-02-25, From 2013-01-01 |
| No annual figure between 2012-03-31 and 2013-12-31. | |||
| 2012-03-31 | -$2.48M | n/m | 2012-05-18, From 2011-04-01 |
| 2011-03-31 | -$5.91M | n/m | 2012-05-18, From 2010-04-01 |
| 2010-03-31 | -$12.25M | n/a | 2012-05-18, From 2009-04-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $520.75M | +18.6% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $68.95M | -13.9% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $711.20M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$27.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $257.63M | +2.4% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $109.84M | -30.4% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$205.48M | n/m |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$189.55M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$268.58M | n/m |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗